| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants Hepatitis Delta Virus, Hepatitis D | Phase 1 | 2025-01-31 |
| Completed | A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjec Recurrent Genital Herpes Simplex Type 2 | Phase 1 | 2024-12-08 |
| Completed | A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic He Chronic Hepatitis B | Phase 1 | 2024-06-04 |
| Completed | A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Recurrent Genital Herpes Simplex Type 2 | Phase 1 | 2024-05-30 |
| Completed | A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy Subjects Chronic Hepatitis B | Phase 1 | 2022-11-11 |
| Completed | A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic H Chronic Hepatitis B | Phase 1 | 2022-08-07 |
| Terminated | A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis Chronic Hepatitis B | Phase 2 | 2021-05-07 |
| Terminated | A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus Infect Chronic Hepatitis B | Phase 2 | 2021-02-18 |
| Completed | A Study to Evaluate the Mass Balance Absorption and AME of VBR Chronic Hepatitis B | Phase 1 | 2020-12-01 |
| Terminated | A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection Chronic Hepatitis B | Phase 2 | 2020-11-11 |
| Terminated | A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection Chronic Hepatitis B | Phase 2 | 2020-08-28 |
| Completed | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABI-H3733 in Healthy Adults Chronic Hepatitis B | Phase 1 | 2020-05-17 |
| Completed | A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Hea Chronic Hepatitis B | Phase 1 | 2019-10-18 |
| Completed | A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults Chronic Hepatitis B | Phase 1 | 2019-09-06 |
| Terminated | ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate | Phase 1 | 2019-06-24 |
| Terminated | A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients Chronic Hepatitis B | Phase 2 | 2018-12-20 |
| Completed | A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B Chronic Hepatitis B | Phase 1 | 2018-11-13 |
| Completed | A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Partici Chronic Hepatitis B | Phase 2 | 2018-06-19 |
| Completed | A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection Chronic Hepatitis B | Phase 2 | 2018-06-11 |
| Completed | Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B Chronic Hepatitis B | Phase 1 / Phase 2 | 2017-06-15 |
| Completed | A Study in Healthy Volunteers and Patients With Chronic Hepatitis B Chronic Hepatitis B | Phase 1 | 2016-11-01 |